DK1295126T3 - Immunoanalysesystemer til påvisning af hepatitis C-virusantigen - Google Patents

Immunoanalysesystemer til påvisning af hepatitis C-virusantigen

Info

Publication number
DK1295126T3
DK1295126T3 DK00952184T DK00952184T DK1295126T3 DK 1295126 T3 DK1295126 T3 DK 1295126T3 DK 00952184 T DK00952184 T DK 00952184T DK 00952184 T DK00952184 T DK 00952184T DK 1295126 T3 DK1295126 T3 DK 1295126T3
Authority
DK
Denmark
Prior art keywords
hepatitis
detection
virus antigen
immunoassay systems
virus
Prior art date
Application number
DK00952184T
Other languages
English (en)
Inventor
David Y Chien
Phillip Arcangel
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of DK1295126T3 publication Critical patent/DK1295126T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00952184T 1999-07-28 2000-07-25 Immunoanalysesystemer til påvisning af hepatitis C-virusantigen DK1295126T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14607999P 1999-07-28 1999-07-28
PCT/US2000/020214 WO2001009609A2 (en) 1999-07-28 2000-07-25 Hepatitis c viral antigen immunoassay detection systems

Publications (1)

Publication Number Publication Date
DK1295126T3 true DK1295126T3 (da) 2007-04-10

Family

ID=22515775

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00952184T DK1295126T3 (da) 1999-07-28 2000-07-25 Immunoanalysesystemer til påvisning af hepatitis C-virusantigen

Country Status (10)

Country Link
EP (1) EP1295126B1 (da)
JP (2) JP5498637B2 (da)
AT (1) ATE352785T1 (da)
CA (1) CA2380777C (da)
CY (1) CY1106349T1 (da)
DE (1) DE60033190T2 (da)
DK (1) DK1295126T3 (da)
ES (1) ES2279766T3 (da)
PT (1) PT1295126E (da)
WO (1) WO2001009609A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0702183D0 (en) * 2007-02-05 2007-03-14 Iti Scotland Ltd Pathogen binding
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
EP3916103A1 (en) 2013-03-14 2021-12-01 Abbott Laboratories Hcv core lipid binding domain monoclonal antibodies
MX2015012824A (es) 2013-03-14 2016-06-24 Abbott Lab Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
JP6505076B2 (ja) 2013-03-14 2019-04-24 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ Ｈｃｖ抗原−抗体組み合わせアッセイおよびこれに使用するための方法および組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
FR2502154A1 (fr) * 1981-03-30 1982-09-24 Trepo Christian Procede de preparation d'antigenes de l'hepatite virale nanb, et application a la realisation d'un reactif permettant le diagnostic et le pronostic des infections provoquees par les virus des hepatites virales
US5308750A (en) * 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
ES2118129T3 (es) * 1991-01-31 1998-09-16 Abbott Lab Anticuerpos monoclonales contra las regiones de cubierta putativas del virus vhc y procedimientos de utilizacion de estos.
AU2683792A (en) * 1991-09-16 1993-04-27 Genelabs Technologies, Inc. Peptide based hepatitis c virus immunoassays
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
GB9214877D0 (en) * 1992-07-14 1992-08-26 Smith Meters Ltd Dry gas meter
JPH06327482A (ja) * 1993-05-21 1994-11-29 Imuno Japan:Kk オリゴペプタイド、オリゴヌクレオチドならびにｃ型肝炎ウ イルス関連抗体検出方法
US6747136B2 (en) * 1996-04-19 2004-06-08 Karolinska Innovations Ab Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
ATE354800T1 (de) * 1997-09-22 2007-03-15 Novartis Vaccines & Diagnostic Verfahren zum nachweiss von antikörpern in einer probe

Also Published As

Publication number Publication date
EP1295126A2 (en) 2003-03-26
ES2279766T3 (es) 2007-09-01
EP1295126B1 (en) 2007-01-24
CA2380777C (en) 2011-01-04
DE60033190T2 (de) 2007-10-31
WO2001009609A3 (en) 2003-01-09
WO2001009609A2 (en) 2001-02-08
DE60033190D1 (de) 2007-03-15
JP5498637B2 (ja) 2014-05-21
JP2010048830A (ja) 2010-03-04
CY1106349T1 (el) 2011-10-12
PT1295126E (pt) 2007-03-30
ATE352785T1 (de) 2007-02-15
JP2003529744A (ja) 2003-10-07
CA2380777A1 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
FI20021626A (fi) Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi
DK1350105T3 (da) Immunoanalyser for enti-HCV-antistoffer
HK1045729A1 (en) Early detection of flavivviruses using the ns1 glycoprotein.
NO870412L (no) Peptider.
WO2004025248A3 (en) Antibody pair screening methods
WO2003095968A3 (fr) Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectueux
WO2002090961A3 (en) Systems and methods for detection of analytes in biological fluids
NO20051715L (no) HCV assay
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
HUP0201087A2 (hu) Hepatitisz-C antigén-antitest kombinációs vizsgálati eljárás a fertőzés korai kimutatására
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
ATE112392T1 (de) Agglutinationskomplex zum nachweis von blutgruppen.
EP1310796A3 (en) Reagents for the simultaneous detection of HCV core antigens and antibodies
TW200722527A (en) Methods of detecting hepatitis C virus
DK1044377T3 (da) Fremgangsmåde til påvisning af Borna disease virus (BDV)-infektioner
ATE295375T1 (de) Antikörper und sonstige bindungsmoleküle gegen hepatitis b virusantigene
ATE174060T1 (de) Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden
NO870461D0 (no) Reagens for paavisning av antistoff mot virusantigener.
ATE228249T1 (de) Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm
UA36086A (uk) Тест-система для підтвердження наявності антитіл проти вірусу гепатиту с (іфа-п-hcv)
DE69925736D1 (de) Lupus antikoagulant-antikörper gegen die f1 region von prothrombin
NO931613L (no) Fremgangsmaate for bestemming av sensiteten og/eller det spesifikke ved et proberingssystem for sporing av antistoffer
GR1004300B (el) Νεα, ανοσοαναλυτικη, μεθοδος προσδιορισμου της φερομονης του δακου της ελιας
BR9801272A (pt) Método de detecção de anticorpos e/ou antígenos